AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Director's Dealing • Jun 27, 2022

3662_dirs_2022-06-27_4698b9cb-16c6-45e7-8301-c0a8988c8d70.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Management in Medistim ASA purchases shares

Management in Medistim ASA has the 27th of June purchased shares form Medistim ASA. This is part of the company long term incentive plan approved by the general meeting the 27th of April 2022. Price per share was NOK 227,49. The following members of management has purchased shares:

VP sales Roger Morberg purchased 2422 shares and has 12849 shares after the purchase.

Chief Business Development Officer Ole Arne Eiksund purchased 2422 shares and has 2462 shares after the purchase.

CEO in Medistim Norge AS purchased 879 shares and has 2205 shares after the purchase.

VP Innovation Håkon Grøthe purchased 2422 shares and has 4411 shares after the purchase.

CFO Thomas Jakobsen purchased 3231 shares and has 25979 shares after the purchase.

Medistim ASA has sold 11376 shares and has 87033 owns shares after the sale.